Venture capital firm New Enterprise Assoc. Inc. (NEA) today announced that it is opening an office in Cambridge’s Kendall Square

The office is located near the MIT campus, the Broad Institute and numerous other venture capital firms.

NEA’s current portfolio of Cambridge- and Boston-area investments includes nearly two dozen healthcare and technology companies, such as the recently public biopharma companies TESARO and Epizyme. The firm is also a founding partner in The Experiment Fund, a seed-stage fund operating on Harvard’s campus.

"From startup to big pharma, the environment for company building, innovation and entrepreneurship has never been better, and Boston’s concentration of talent and capabilities is unrivaled," David Mott, NEA General Partner and head of the firm’s healthcare investing practice, said in a statement. "Anchoring the firm’s presence in Kendall Square will enable us to work more closely with our entrepreneurs and partners, and to aggressively seek new investment opportunities."